“预后控制”策略中的干预目标制订和干预时机选择
|
摘要
<正>医疗行为的目的是追求患者预后最优化。在这一过程中,需要审慎评价干预者、干预手段和疾病风险三个客观因素的相互作用,以最小化疾病风险为目标,选择最佳的干预者和干预手段组合,可以将此称为医学行为中的"预后控制"策略[1]。实施这一策略的过程,即为疾病的"风险管理"过程[2]。而在
引文
1刘荣.医疗干预应聚焦预后---医学中的动态预后控制[J].解放军医学院学报,2018,39(11):931-933.
2刘荣.智能医学---智能时代与新时代的医学[M].北京:人民卫生出版社,2018.
3刘荣,刘渠.术中风险预控与肝胆胰微创外科[J/CD].中华腔镜外科杂志(电子版),2017,10(2):65-67.
4 Fuchs KH.Minimally invasive surgery[J].Endoscopy,2009,34(2):154-159.
5 Tanno S,Nakano Y,Nishikawa T,et al.Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules:long-term follow-up results[J].Gut,2008,57(3):339-343.
6 Fritz S,Hackert T,Hinz U,et al.Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas[J].British Journal of Surgery,2012,99(9):1315-1315.
2刘荣.智能医学---智能时代与新时代的医学[M].北京:人民卫生出版社,2018.
3刘荣,刘渠.术中风险预控与肝胆胰微创外科[J/CD].中华腔镜外科杂志(电子版),2017,10(2):65-67.
4 Fuchs KH.Minimally invasive surgery[J].Endoscopy,2009,34(2):154-159.
5 Tanno S,Nakano Y,Nishikawa T,et al.Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules:long-term follow-up results[J].Gut,2008,57(3):339-343.
6 Fritz S,Hackert T,Hinz U,et al.Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas[J].British Journal of Surgery,2012,99(9):1315-1315.